American Cancer Society updates prostate cancer screening guideline: Regular PSA testing for average- and high-risk men
The American Cancer Society (ACS) today released an updated guideline for prostate cancer screening to help find cancer before it spreads and reduce the risk of dying from the disease. Key changes include a direct recommendation for prostate-specific antigen (PSA)-based screening every two years for average-risk men aged 50–69, with clinicians ensuring patients understand the potential benefits,…
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
A microbe-made molecule may reverse gut damage by boosting NAD levels
United Kingdom
-
Longer inhibitory connections can push simulated neural networks beyond critical tipping point
United Kingdom
-
AHA: More intensive blood pressure lowering cuts future cardiovascular risk after stroke, transient ischemic attack
United Kingdom
-
Newly identified enzyme protects growth protein in leukemia cells
United Kingdom
-
Forever chemical disturbs early development in stem cell model
United Kingdom
-
Older AI-estimated heart age linked to worse health outcomes
United Kingdom
-
Dr. King’s Lost Draft of ‘I Have a Dream’ Emerges from a Desk Drawer
United Kingdom
-
Blood NAD levels track heart disease, not aging, study of more than 1,000 adults finds
United Kingdom